WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical prices take centre stage in his administration's messaging around affordability ...

A pharmaceutical executive collapsed during an event where president Donald Trump announced a new initiative for subsidized ...

U.S. President Donald Trump on Thursday struck deals with obesity drug manufacturers Eli Lilly and Novo Nordisk aimed at ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

Biden’s Inflation Reduction Act, which passed in 2022, requires pharmaceutical companies to negotiate drug prices with ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

A federal appeals court on Thursday revived President Donald Trump’s effort to move his New York hush money conviction into ...

It appears that President Donald Trump’s angry social media posts have once again landed him in hot water in the courts: a ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...

Pandemonium broke out at the Oval Office on Thursday when a pharmaceutical representative standing beside President Donald ...